13F-HR filed by THOMPSON INVESTMENT MANAGEMENT, INC.
THOMPSON INVESTMENT MANAGEMENT, INC. filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-10-15, with 507 holding rows worth $700,390,792.
- Accession
- 0001277279-24-000008
- Filer
- CIK 1277279
- Filed
- 2024-10-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 515 entries on the cover page, a total value of $700,390,792 stated on the cover page (in dollars after the unit check, H1), rows summing to $700,390,792 with VALUE read as dollars as filed, 13F file number 028-10877. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REGEN BIOPHARMA INC PFD SER A | 75886m409 | PFD | 8 | $2 | dollars as filed | |
| LUCID DIAGNOSTICS INC | 54948X109 | COM | 1 | $1 | dollars as filed | |
| VSBLTY GROUPE TECHNOLOGIES COR | 91834N605 | USD | 20 | $1 | dollars as filed | |
| REGEN BIOPHARMA INC COM NEW | 75886M300 | COM | 4 | $1 | dollars as filed | |
| ACCESS POWER & CO INC | 00431N108 | COM | 200 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| CONTRA ACER THERAPEUTICS | 004cvr049 | WT | 10 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| VIVA ENTMT GROUP INC COM NEW | 92852K200 | COM | 900 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001277279-24-000008 | this filing | 2024-10-15 | acceptance time not in the bulk data set |